Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Ryan Specialty (RYAN)

Ryan Specialty Q4 revenue rises 13.2%; net income falls 26.6%

Mixed Impact 4 of 5 earnings Written later

Ryan Specialty reported fourth-quarter 2025 total revenue of $751.2 million, up 13.2%, while net income fell 26.6% to $31.2 million. The board also approved a three-year Empower restructuring program with about $160 million of pre-tax charges, a $300 million share repurchase authorization and an 8.3% dividend increase, which affects shareholders through near-term charges and capital returns.

Key points

  • Q4 2025 total revenue $751.2 million, up 13.2%; net income $31.2 million, down 26.6%; diluted EPS $0.06
  • Adjusted diluted EPS flat at $0.45; Adjusted EBITDAC margin 29.6% versus 32.6% a year earlier
  • Empower Program: about $160 million of cumulative pre-tax charges through 2028, with about $80 million of annual savings expected in 2029
  • $300 million share repurchase authorization; quarterly dividend raised 8.3% to $0.13, payable March 10, 2026

The filing

CompanyRyan Specialty (RYAN)
Form8-K, current report
Filed with the SECFeb 12, 2026, 4:07 PM ET
Accession number0001849253-26-000004

Items reported: 2.02 Results of Operations2.05 Exit / Restructuring Costs7.01 Regulation FD Disclosure8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 2:07 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 12, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.